Literature DB >> 21609305

Comparison of human bone marrow mononuclear cell isolation methods for creating tissue-engineered vascular grafts: novel filter system versus traditional density centrifugation method.

Narutoshi Hibino1, Ani Nalbandian, Lesley Devine, Rajendra Sawh Martinez, Edward McGillicuddy, Tai Yi, Safa Karandish, Girolamo A Ortolano, Toshiharu Shin'oka, Edward Snyder, Christopher K Breuer.   

Abstract

INTRODUCTION: We created the first tissue-engineered vascular graft (TEVG) to be successfully used in humans. The TEVG is made by seeding autologous bone marrow-derived mononuclear cells (BM-MNCs) onto a biodegradable tubular scaffold fabricated from polyglycolic-acid mesh coated with a 50:50 copolymer of poly-L-lactide and-ɛ-caprolactone. In the initial clinical study, the BM-MNCs were isolated using a Ficoll density centrifugation method. Use of this cell isolation technique is problematic in that it is performed using an open system and therefore is susceptible to contamination. As a first step toward creating a closed system for assembling a TEVG, we evaluated the use of a filter-based method for isolating BM-MNCs and compared it to density centrifugation in Ficoll.
METHODS: BM-MNCs were isolated from human BM using density centrifugation in Ficoll or a filter-based method. BM-MNCs were seeded onto biodegradable tubular scaffold and incubated for 24 h before implantation. The TEVG were implanted as inferior vena cava interposition grafts in SCID/bg mice (n=24) using microsurgical technique. Grafts were followed with ultrasonography and computed tomography-angiography. Ten weeks after implantation the TEVG were explanted and examined using histology and immunohistochemistry.
RESULTS: Both methods isolated similar number of cells (Ficoll: 8.5±6.6×10(6)/mL, Filter: 6.6±3.5×10(6)/mL; p=0.686) with similar viability as assayed using fluorescence-activated cell sorting (FACS) (Ficoll: 97.0%±1.5%, Filter: 95.9%±3.0%; p=0.339). FACS analysis demonstrated that the fraction of lymphocytes and monocytes to total cells was lower in the filter group (CD4 in Ficoll: 8.9%±1.1%, CD4 in Filter: 3.5%±0.8%; p=0.002, CD8 in Ficoll: 9.4%±2.1%, CD8 in Filter: 3.9%±1.4%; p=0.021, Monocyte in Ficoll: 6.9%±1.0%, Monocyte in Filter: 2.7%±1.0%; p=0.008), consistent with granulocyte contamination (Ficoll: 46.6±2.7×10(6)/mL, Filter: 58.1±5.2×10(6)/mL; p<0.001). The ratio of stem cells to BM-MNCs was comparable between groups. There were no statistically significant differences with regard to TEVG patency and morphology between groups. Both methods of cell isolation produced neovessels with similar histology.
CONCLUSION: Filter-based BM-MNC isolation is comparable to BM-MNC isolation using density centrifugation in Ficoll for TEVG assembly. The filter-based cell isolation technique has the added advantage of the potential to create a closed disposable system. © Mary Ann Liebert, Inc.

Entities:  

Mesh:

Year:  2011        PMID: 21609305      PMCID: PMC3182675          DOI: 10.1089/ten.TEC.2011.0110

Source DB:  PubMed          Journal:  Tissue Eng Part C Methods        ISSN: 1937-3384            Impact factor:   3.056


  17 in total

1.  Filter Buffy Coats (FBC): a source of peripheral blood leukocytes recovered from leukocyte depletion filters.

Authors:  T P H Meyer; I Zehnter; B Hofmann; J Zaisserer; J Burkhart; S Rapp; F Weinauer; J Schmitz; W E Illert
Journal:  J Immunol Methods       Date:  2005-11-17       Impact factor: 2.303

2.  Ficoll-Paque versus Lymphoprep: a comparative study of two density gradient media for therapeutic bone marrow mononuclear cell preparations.

Authors:  Chia Yeo; Natalie Saunders; Didier Locca; Andy Flett; Melanie Preston; Pat Brookman; Barbara Davy; Anthony Mathur; Samir Agrawal
Journal:  Regen Med       Date:  2009-09       Impact factor: 3.806

3.  Development of a model system for preliminary evaluation of tissue-engineered vascular conduits.

Authors:  Amit Goyal; Yinong Wang; Haili Su; Lawrence W Dobrucki; Matthew Brennan; Peter Fong; Alan Dardik; George Tellides; Albert Sinusas; Jordan S Pober; W Mark Saltzman; Christopher K Breuer
Journal:  J Pediatr Surg       Date:  2006-04       Impact factor: 2.545

4.  Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction.

Authors:  Ketil Lunde; Svein Solheim; Svend Aakhus; Harald Arnesen; Michael Abdelnoor; Torstein Egeland; Knut Endresen; Arnfinn Ilebekk; Arild Mangschau; Jan G Fjeld; Hans Jørgen Smith; Eli Taraldsrud; Haakon Kiil Grøgaard; Reidar Bjørnerheim; Magne Brekke; Carl Müller; Einar Hopp; Asgrimur Ragnarsson; Jan E Brinchmann; Kolbjørn Forfang
Journal:  N Engl J Med       Date:  2006-09-21       Impact factor: 91.245

5.  Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction.

Authors:  Volker Schächinger; Sandra Erbs; Albrecht Elsässer; Werner Haberbosch; Rainer Hambrecht; Hans Hölschermann; Jiangtao Yu; Roberto Corti; Detlef G Mathey; Christian W Hamm; Tim Süselbeck; Birgit Assmus; Torsten Tonn; Stefanie Dimmeler; Andreas M Zeiher
Journal:  N Engl J Med       Date:  2006-09-21       Impact factor: 91.245

6.  Midterm clinical result of tissue-engineered vascular autografts seeded with autologous bone marrow cells.

Authors:  Toshiharu Shin'oka; Goki Matsumura; Narutoshi Hibino; Yuji Naito; Manabu Watanabe; Takeshi Konuma; Takahiko Sakamoto; Masayoshi Nagatsu; Hiromi Kurosawa
Journal:  J Thorac Cardiovasc Surg       Date:  2005-06       Impact factor: 5.209

7.  Cell isolation procedures matter: a comparison of different isolation protocols of bone marrow mononuclear cells used for cell therapy in patients with acute myocardial infarction.

Authors:  Florian H Seeger; Torsten Tonn; Nicola Krzossok; Andreas M Zeiher; Stefanie Dimmeler
Journal:  Eur Heart J       Date:  2007-02-13       Impact factor: 29.983

8.  Small-diameter biodegradable scaffolds for functional vascular tissue engineering in the mouse model.

Authors:  Jason D Roh; Gregory N Nelson; Matthew P Brennan; Tamar L Mirensky; Tai Yi; Tyrone F Hazlett; George Tellides; Albert J Sinusas; Jordan S Pober; W M Saltzman; Themis R Kyriakides; Christopher K Breuer
Journal:  Biomaterials       Date:  2007-12-27       Impact factor: 12.479

9.  Tissue-engineered vascular grafts demonstrate evidence of growth and development when implanted in a juvenile animal model.

Authors:  Matthew P Brennan; Alan Dardik; Narutoshi Hibino; Jason D Roh; Gregory N Nelson; Xenophon Papademitris; Toshiharu Shinoka; Christopher K Breuer
Journal:  Ann Surg       Date:  2008-09       Impact factor: 12.969

10.  Evaluation of tissue-engineered vascular autografts.

Authors:  Goki Matsumura; Yoko Ishihara; Sachiko Miyagawa-Tomita; Yoshito Ikada; Shojiro Matsuda; Hiromi Kurosawa; Toshiharu Shin'oka
Journal:  Tissue Eng       Date:  2006-11
View more
  21 in total

Review 1.  Concise review: guidance in developing commercializable autologous/patient-specific cell therapy manufacturing.

Authors:  Shannon Eaker; Myriam Armant; Harvey Brandwein; Scott Burger; Andrew Campbell; Carmine Carpenito; Dominic Clarke; Timothy Fong; Ohad Karnieli; Knut Niss; Wouter Van't Hof; Ravenska Wagey
Journal:  Stem Cells Transl Med       Date:  2013-10-07       Impact factor: 6.940

2.  Comparison of the biological equivalence of two methods for isolating bone marrow mononuclear cells for fabricating tissue-engineered vascular grafts.

Authors:  Hirotsugu Kurobe; Shuhei Tara; Mark W Maxfield; Kevin A Rocco; Paul S Bagi; Tai Yi; Brooks V Udelsman; Ethan W Dean; Ramak Khosravi; Heather M Powell; Toshiharu Shinoka; Christopher K Breuer
Journal:  Tissue Eng Part C Methods       Date:  2014-12-29       Impact factor: 3.056

3.  High-efficiency rare cell identification on a high-density self-assembled cell arrangement chip.

Authors:  Tsung-Ju Chen; Jen-Kuei Wu; Yu-Cheng Chang; Chien-Yu Fu; Tsung-Pao Wang; Chun-Yen Lin; Hwan-You Chang; Ching-Chang Chieng; Chung-Yuh Tzeng; Fan-Gang Tseng
Journal:  Biomicrofluidics       Date:  2014-05-12       Impact factor: 2.800

Review 4.  Tissue-engineered vascular grafts for congenital cardiac disease: Clinical experience and current status.

Authors:  Joseph D Drews; Hideki Miyachi; Toshiharu Shinoka
Journal:  Trends Cardiovasc Med       Date:  2017-06-21       Impact factor: 6.677

5.  Intravascular Ultrasound Characterization of a Tissue-Engineered Vascular Graft in an Ovine Model.

Authors:  Victoria K Pepper; Elizabeth S Clark; Cameron A Best; Ekene A Onwuka; Tadahisa Sugiura; Eric D Heuer; Lilamarie E Moko; Shinka Miyamoto; Hideki Miyachi; Darren P Berman; Sharon L Cheatham; Joanne L Chisolm; Toshiharu Shinoka; Christopher K Breuer; John P Cheatham
Journal:  J Cardiovasc Transl Res       Date:  2017-01-17       Impact factor: 4.132

6.  Comparison of a closed system to a standard open technique for preparing tissue-engineered vascular grafts.

Authors:  Hirotsugu Kurobe; Mark W Maxfield; Yuji Naito; Muriel Cleary; Mitchel R Stacy; Daniel Solomon; Kevin A Rocco; Shuhei Tara; Avione Y Lee; Albert J Sinusas; Edward L Snyder; Toshiharu Shinoka; Christopher K Breuer
Journal:  Tissue Eng Part C Methods       Date:  2015-01       Impact factor: 3.056

7.  Factors Influencing Poor Outcomes in Synthetic Tissue-Engineered Tracheal Replacement.

Authors:  Victoria Pepper; Cameron A Best; Kaila Buckley; Cynthia Schwartz; Ekene Onwuka; Nakesha King; Audrey White; Sayali Dharmadhikari; Susan D Reynolds; Jed Johnson; Jonathan Grischkan; Christopher K Breuer; Tendy Chiang
Journal:  Otolaryngol Head Neck Surg       Date:  2019-04-30       Impact factor: 3.497

Review 8.  Diabetes-associated macrovascular complications: cell-based therapy a new tool?

Authors:  Maddalena Gili; Alberto Orsello; Sara Gallo; Maria Felice Brizzi
Journal:  Endocrine       Date:  2013-03-30       Impact factor: 3.633

Review 9.  Biomaterials and heart recovery: cardiac repair, regeneration and healing in the MCS era: a state of the "heart".

Authors:  Sveva Di Franco; Cristiano Amarelli; Andrea Montalto; Antonio Loforte; Francesco Musumeci
Journal:  J Thorac Dis       Date:  2018-07       Impact factor: 2.895

Review 10.  Fabrication of tissue-engineered vascular grafts with stem cells and stem cell-derived vascular cells.

Authors:  Lunchang Wang; Jiang Hu; Claire E Sorek; Eugene Y Chen; Peter X Ma; Bo Yang
Journal:  Expert Opin Biol Ther       Date:  2015-12-08       Impact factor: 4.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.